tiprankstipranks
Arcus Biosciences price target raised to $29 from $25 at Barclays
PremiumThe FlyArcus Biosciences price target raised to $29 from $25 at Barclays
2M ago
Arcus Biosciences Reports Promising Trial Results
Premium
Company Announcements
Arcus Biosciences Reports Promising Trial Results
2M ago
Arcus Biosciences price target raised to $46 from $38 at Citi
Premium
The Fly
Arcus Biosciences price target raised to $46 from $38 at Citi
2M ago
Arcus Biosciences initiated with an Overweight at Wells Fargo
PremiumThe FlyArcus Biosciences initiated with an Overweight at Wells Fargo
3M ago
Arcus announces clinical trial collaboration pact to evaluate casdatifan combo
Premium
The Fly
Arcus announces clinical trial collaboration pact to evaluate casdatifan combo
3M ago
Arcus Biosciences reports Q2 EPS ($1.02), consensus ($1.10)
Premium
The Fly
Arcus Biosciences reports Q2 EPS ($1.02), consensus ($1.10)
5M ago
Arcus Biosciences price target lowered to $25 from $35 at Barclays
PremiumThe FlyArcus Biosciences price target lowered to $25 from $35 at Barclays
6M ago
Arcus Biosciences drops 6% after Roche lung cancer failure
Premium
The Fly
Arcus Biosciences drops 6% after Roche lung cancer failure
6M ago
Roche failure likely worst case for Arcus study, says Cantor Fitzgerald
Premium
The Fly
Roche failure likely worst case for Arcus study, says Cantor Fitzgerald
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100